FDA Approved: SODIUM IODIDE I-131 — Original Application (Radnostix, Inc.)

View source ↗

Summary

FDA approved the original application for Sodium Iodide I-131 (Radnostix, Inc.), a radiopharmaceutical used to treat hyperthyroidism and thyroid cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperthyroidism
• Thyroid Cancer

Drugs mentioned

• Sodium Iodide I-131 (Sodium iodide I-131)

Snippet

ORIG AP for SODIUM IODIDE I-131 (SODIUM IODIDE I-131)